People who took Zepbound had greater reductions in waist circumference and body weight, a study found.Fact checked by Nick ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Novo Nordisk told Reuters in a statement that a similar dose of Wegovy led to greater weight loss in a 2021 trial ... Zepbound shed about 50.3 pounds, on average, while those who used Wegovy ...

By the end of the study, people on the maximum dose of Zepbound lost an average of about 50 ... lb (13.7 percent of their body weight) with Wegovy. More weight loss wasn’t the only advantage ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy.

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

They have been called miraculous and the fastest way to lose weight. From Wegovy to Mounjaro, here’s how GLP-1 drugs work ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

The Danish diabetes drug is now officially available for weight loss in Czechia, offering a medically supervised option to ...